Researchers have made a significant discovery that could fundamentally change how Parkinson’s disease is treated. Scientists identified GPNMB, a protein released by immune cells that inadvertently accelerates the spread of Parkinson’s pathology through the brain. When neurons are damaged, microglial cells release GPNMB in what should be a protective response. Instead, this protein facilitates the transfer of toxic alpha-synuclein aggregates to healthy neighboring neurons, creating a destructive cascade. Early laboratory experiments demonstrate that antibody treatments designed to block GPNMB successfully prevented this spreading mechanism. This breakthrough offers hope for developing therapies that address the root cause of disease progression rather than merely managing symptoms. The discovery explains why Parkinson’s advances in predictable patterns across different brain regions, opening new avenues for therapeutic intervention.
Was this article helpful?
